Fluticasone furoate and vilanterol and survival in chronic obstructive pulmonary disease with heightened cardiovascular risk (SUMMIT): a double-blind randomised controlled trial
Year: 2016
Type: article
Study designs: Randomized Controlled Trial, Clinical Trial
Source: The Lancet
Institutions: Manchester Academic Health Science Centre, University of Manchester, GlaxoSmithKline (United Kingdom), Michigan Medicine, University of Liverpool, Aintree University Hospital, Brigham and Women's Hospital, Harvard University, GlaxoSmithKline (United States), Weill Cornell Medicine, University of Edinburgh
Language: English
Subfield: Pulmonary and Respiratory Medicine
Field: Medicine
Domain: Health Sciences
Open Access status: green
Funder: GlaxoSmithKline
OpenAlex ID: W2344148139